Study of BW-50218 in Healthy Participants
This trial tests a new medicine, BW-50218, in healthy volunteers to see how safe it is and how the body processes it. If you are generally healthy and meet the specific requirements below, you may be able to help with early research on this potential treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be willing to sign a consent form and follow study rules for the whole study.
- Weigh an amount and have a body mass index (BMI) that the study doctor considers healthy for this trial.
- If you are a woman, you must not be pregnant or nursing, and you must either be unable to become pregnant or use highly effective birth control.
- If you are a man with a partner who could become pregnant, you must agree to use effective birth control.
- Have no major medical conditions, recent serious illness, or lab results that the study doctor thinks might make the study unsafe or affect your participation.
- Test negative for hepatitis B, hepatitis C, and HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This study tests a new medicine called BW-40202 for the first time in people. It is for healthy volunteers to see if the drug is safe and how it works in the body. You must be in good general health to take part.
This is an early-stage (Phase 1) safety test of a new investigational drug called BW-20805-2-1001 in people without serious health conditions. Researchers want to understand how the drug is tolerated and processed by the body when given as an injection.
This study tests a new injection called BPR-30221616 to see how safe it is and how people tolerate it. It is for healthy volunteers and will help find the right dose for future studies.
This study tests a new experimental injection in healthy volunteers to see if it's safe and how well the body absorbs it. Researchers will compare it with other similar treatments to understand how it works.
This trial tests a single dose of an experimental medicine called EB070 in healthy people. It checks how the drug moves through the body and if it causes side effects. You may be able to join if you are a generally healthy adult.
Hear when a new Healthy Participants Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.